Patent Application
Utility
App. No. 17/814,474
· Confirmation No. 2002
TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT
Applicant:
BAUSCH HEALTH IRELAND LIMITED
Non Final Action Mailed
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-05-06 | CTNF |
Non-Final Rejection | 9 | View | |
| 2026-05-06 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2026-05-06 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2026-05-06 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2026-05-06 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2026-05-06 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2026-03-23 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | — | View | |
| 2026-03-23 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2026-03-23 | RCEX |
Request for Continued Examination (RCE) | 3 | View | |
| 2026-03-23 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2026-03-23 | CLM |
Claims | 3 | View | |
| 2026-03-23 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2026-03-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2026-03-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2026-01-06 | CTFR |
Final Rejection | 12 | View | |
| 2026-01-06 | EXIN |
Examiner Interview Summary Record (PTOL - 413) | 1 | View | |
| 2026-01-06 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2026-01-06 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2026-01-06 | SRNT |
Examiner's search strategy and results | 4 | View | |
| 2026-01-06 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-11-11 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | — | View | |
| 2025-11-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2025-11-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-11-11 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2025-11-11 | CLM |
Claims | 3 | View | |
| 2025-11-11 | REM |
Applicant Arguments/Remarks Made in an Amendment | 5 | View | |
| 2025-11-11 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-11-11 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-08-12 | CTNF |
Non-Final Rejection | 8 | View | |
| 2025-08-12 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2025-08-12 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2025-08-12 | 1449 |
List of References cited by applicant and considered by examiner | 1 | View | |
| 2025-08-12 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-08-12 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-07-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-07-22 | ELC. |
Response to Election / Restriction Filed | 2 | View | |
| 2025-07-22 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2025-06-04 | CTRS |
Requirement for Restriction/Election | 8 | View | |
| 2024-08-16 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-08-16 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-08-12 | PA.. |
Power of Attorney | 2 | View | |
| 2024-08-12 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-08-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-11-23 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-08-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-08-12 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-08-03 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-08-03 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2022-08-03 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-08-02 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-07-22 | PA.. |
Power of Attorney | 3 | View | |
| 2022-07-22 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2022-07-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2022-07-22 | ABST |
Abstract | 1 | View | |
| 2022-07-22 | SPEC |
Specification | 56 | View | |
| 2022-07-22 | CLM |
Claims | 1 | View | |
| 2022-07-22 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 5 | View | |
| 2022-07-22 | FOR |
Foreign Reference | 137 | View | |
| 2022-07-22 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-07-22 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2022-07-22 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-07-22 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2022-07-22 | FOR |
Foreign Reference | 42 | View | |
| 2022-07-22 | ADS |
Application Data Sheet | 9 | View | |
| 2022-07-22 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-07-22 | SPEC |
Specification | 1 | View | |
| 2022-07-22 | ABST |
Abstract | 1 | View | |
| 2022-07-22 | CLM |
Claims | 3 | View | |
| 2022-07-22 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-07-22 | ABST |
Abstract | — | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
514/291
A61P17/00
A61K31/454
A61P17/06
A61K9/0014
A61K9/06
A61K31/225
A61K31/436
A61K47/02
A61K47/10
A61K47/14
A61K47/183
A61K47/20
A61K47/32
A61K2300/00
Prosecution
- Examiner
- SOROUSH, LAYLA
- Art Unit
- 1622
- Customer No.
- 193452
- Docket No.
- 134003-5072-US
- Confirmation No.
- 2002
Publication
- Pub. No.
- US20220362232A1
- Pub. Date
- 2022-11-17
Parent
PCT
is a Continuation of
→
PCT/EP2021/051478
Filed 2021-01-22
· Non Final Action Mailed
Parent
Claims priority from a provisional application
→
App. 62/964,516
Filed 2020-01-22
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/964,507
Filed 2020-01-22
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/964,495
Filed 2020-01-22
· Provisional Application Expired
U.S. PATENT SECURITY AGREEMENT
Recorded 2025-11-25
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2023-02-24
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-11-04
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-11-04
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-11-01
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-10-05
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-10-04
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/814,474
- Filed
- 2022-07-22
- Pub. No.
- US20220362232A1
- Examiner
- SOROUSH, LAYLA
- Art Unit
- 1622
External Links